Lemaitre Vascular (LMAT) Debt to Equity (2020 - 2021)

Lemaitre Vascular (LMAT) reported Debt to Equity of $0.14 for Q2 2021, down 66.28% year-over-year from $0.41 in Q2 2020, and up 774.08% quarter-over-quarter from $0.02 in Q1 2021.

Lemaitre Vascular (LMAT) Debt to Equity (2020 - 2021) Analysis & Trends

Lemaitre Vascular (LMAT) has 2 years of Debt to Equity data on file, last reported at $0.14 in Q2 2021.

  • Debt to Equity for Q2 2021 came in at $0.14, down 66.28% year-over-year; the trailing twelve-month figure through Jun 2021 was $0.14 (down 66.28% YoY), and the FY2020 annual result was $0.22, changed N/A from the prior year.
  • Debt to Equity advanced to $0.14 in Q2 2021 per LMAT's latest filing, from $0.02 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.41 in Q2 2020 and troughed at $0.02 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 0.72
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 1.12
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 0.04
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 0.07
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 1.02
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 0.30
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 1.57
10 Lemaitre Vascular 2.12 Bn 1.75 Bn 48.40 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 0.14
Mar 31, 2021 0.02
Dec 31, 2020 0.22
Sep 30, 2020 0.36
Jun 30, 2020 0.41